Article record

全球阻塞性睡眠呼吸暂停倡议（GIFOSA）：依据、战略框架与行动呼吁。

The Global Initiative for Obstructive Sleep Apnea (GIFOSA): Rationale, Strategic Framework, and Call to Action.

指南共识鼻科IF 3Q2

文献信息

PMID	42768286
原文	在 PubMed 查看原文 ↗
发表日期	2026
作者	Sy Duong-Quy 查看其他 43 位作者 Naricha Chirakalwasan；Tayard Desudchit；Stanley Yung-Chuan Liu；Leow Leong Chai；Thien Thanh Dang-Vu；Hiroshi Kadotani；Sang-Ha Kim；Hyung Chae Yang；Rodolfo V Dizon；Ravi Gupta；Allen Widysanto；Rusdi Bin Abd Rashid；Yap Yoke Yeow；Jianchen Cui；Mohammed A Al-Abri；Mouhamad Ghyath Jamil；Hamza Dhafar；Babak Amra；Pei-Lin Lee；Kiong Fou Yoom；Glenn Roldan；Carlos Teixeira；Kouassi Boko Alexandre；Amine Benjelloun；Franck-Hardain Okemba-Okombi；Chan Sarin；Thai Nguyen-Duy；Dung Nguyen-Thi-Thu；Huong Le-Thi-Minh；Thuy Tran-Phan-Chung；Linh Pham-Van；Giap Vu-Van；Vinh Nguyen-Nhu；Bao Le-Khac；Nhung Nguyen-Viet；Franck Soyez；Véronique Bricout；Fannie Onen；Francis Martin；Ahmed BaHammam；Thomas Penzel；Timothy Craig；Clete Kushida
作者单位	Department of Sleep Medicine, University of Medicine and Pharmacy, Hanoi National University, Hanoi, Vietnam. sduongquy.jfvp@gmail.com. 查看其他 37 条单位信息 Penn State Medical College University, University Park, PA, USA. sduongquy.jfvp@gmail.com.；Division of Pulmonary and Critical Care Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.；Excellence Center for Sleep Disorders, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.；Division of Pediatric Neurology at Chulalongkorn University, Bangkok, Thailand.；NSU Health Breathe & Sleep Wellness Center, Nova Southeastern University, Fort Lauderdale, FL, USA.；SingHealth Duke-NUS Sleep Centre, Singapore, Singapore.；Sleep, Cognition & Neuroimaging Laboratory, Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal (CRIUGM) & Concordia University, Montreal, Canada.；Shiga University of Medical Science, Otsu, Shiga, Japan.；Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.；Department of Otolaryngology, Head and Neck Surgery, Chonnam National University Medical School, Gwangju, Republic of Korea.；University of Perpetual Help Dalta Medical Center, Las Piñas, Philippines.；Department of Psychiatry and Division of Sleep Medicine, All India Institute of Medical Sciences, Veerbhadra Marg, Rishikesh, India.；Department of Respirology, University of Pelita Harapan, Tangerang, Banten, Indonesia.；University Malaya Specialist Centre, Kuala Lumpur, Malaysia.；KPJ Johor Specialist Hospital, Johor Bahru, Malaysia.；Department of Sleep Medicine, The First People's Hospital of Yunnan Province, Kunming, China.；Department of Clinical Physiology, Sultan Qaboos University, Seeb, Oman.；King Faisal Hospital and Research Center, Riyadh, Saudi Arabia.；University Sleep Disorders Center, King Khalid University Hospital King Saud University, Riyadh, Saudi Arabia.；Isfahan University of Medical Sciences, Isfahan, Iran.；Sleep and Chronobiology Center, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan.；International Nox Medical Group, Asia Region, Singapore, Singapore.；Network of Asia-Pacific Sleep Specialists, NeuroSleep Ctr of the Philippines, Taguig, Philippines.；Polytechnic and University Higher Education Cooperative, CRL, Gandra, Portugal.；Sleep Society of Côte d'Ivoire University Medical Center, Cocody, Ivory Coast.；Pulmonary Department, Avicenne Military Hospital, Marrakech, Maroc.；Ministry of Health and Population Faculty of Health Sciences, UMNG, Brazzaville, Republic of the Congo.；Cambodian Association of Sleep Medicine Calmette Hospital, Phnom Penh, Cambodia.；Department of Sleep Medicine, University of Medicine and Pharmacy, Hanoi National University, Hanoi, Vietnam.；Executive Board Committee, Vietnam Society of Sleep Medicine, Xuan Huong-Da Lat, Lam Dong, Vietnam.；French, Vietnamese Association of Pulmonology, Paris, France.；Medical Unit of Sport, Health and Prevention, INSERM U1300, University Hospital of Grenoble, Grenoble, France.；INSERM U1018 & CESP, Paris-Saclay University, & Sleep Center, Ambroise Paré Hospital, APHP, Paris, France.；University Sleep Disorders Center. College of Medicine, King Saud University, Riyadh, Saudi Arabia.；Interdisciplinary Sleep Medicine Centre, Charité Hospital, Universitätsmedizin Berlin, Berlin, Germany.；Penn State Medical College University, University Park, PA, USA. tcraig@pennstatehealth.psu.edu.；Department of Psychiatry and Behavioral Sciences, Stanford University Center for Human Sleep Research, Stanford, CA, USA. clete@stanford.edu.
期刊	Pulmonary therapy
SCI 分区	Q2
IF	3
研究类型	指南共识 · 临床
所属专科	鼻科

中文摘要

背景： 阻塞性睡眠呼吸暂停（OSA）是全球最常见的慢性睡眠障碍之一，估计影响全球近十亿成年人，并日益被认为是心脏代谢疾病、生活质量受损和医疗费用不断上升的主要因素。尽管在理解OSA病理生理学、诊断和治疗方面取得了实质性进展，但在不同地区和医疗系统之间，在获得护理、实施循证实践和长期结局方面仍存在显著差异。全球阻塞性睡眠呼吸暂停倡议（GIFOSA）作为一个以实施为重点的倡议而成立，旨在通过协调的多学科框架应对这些挑战，该框架超越现有的区域和国家努力，整合全球协调、面向行动的实施策略、实用工具和政策参与。本文介绍了GIFOSA的概念基础，并概述了其战略支柱：加强临床和科学基础、建设劳动力能力、推进以人为本的管理，以及将OSA纳入人口健康和政策议程。其务实结构的核心是关注实施可行性，包括情境敏感的护理路径、任务分担方法，以及可在不同资源水平采用的、技术支持的诊断和管理策略。通过强调跨学科合作、技术创新以及与卫生系统和政策优先事项的一致性，GIFOSA旨在弥合知识与实践之间的差距，同时促进公平获得诊断和治疗。该倡议进一步强调了预防、数字健康整合和全球研究合作的重要性，以支持全球OSA护理可持续和可衡量的改善。图形摘要随本文提供。

英文摘要

Obstructive sleep apnea (OSA) is one of the most prevalent chronic sleep disorders worldwide, affecting an estimated nearly one billion adults globally, and is increasingly recognized as a major contributor to cardiometabolic disease, impaired quality of life, and escalating healthcare costs. Despite substantial advances in understanding OSA pathophysiology, diagnosis, and treatment, significant disparities persist in access to care, implementation of evidence-based practice, and long-term outcomes across regions and healthcare systems. The Global Initiative for Obstructive Sleep Apnea (GIFOSA) was established as an implementation-focused initiative to address these challenges through a coordinated, multidisciplinary framework that goes beyond existing regional and national efforts by integrating global coordination, action-oriented implementation strategies, practical tools, and policy engagement. This paper presents the conceptual foundations of GIFOSA and outlines its strategic pillars: strengthening clinical and scientific foundations, building workforce capacity, advancing person-centered management, and integrating OSA into population health and policy agendas. Central to its pragmatic structure is a focus on implementation feasibility, including context-sensitive care pathways, task-sharing approaches, and technology-enabled diagnostics and management strategies that can be adopted across resource levels. By emphasizing cross-disciplinary collaboration, technological innovation, and alignment with health systems and policy priorities, GIFOSA seeks to bridge the gap between knowledge and practice while promoting equitable access to diagnosis and treatment. The initiative further highlights the importance of prevention, digital health integration, and global research collaboration to support sustainable and measurable improvements in OSA care worldwide.Graphical Abstract is available with this article.